Sarikidi, A.; Kefalakes, E.; Falk, C.S.; Esser, R.; Ganser, A.; Thau-Habermann, N.; Petri, S.
Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS. Biomedicines 2022, 10, 2916.
https://doi.org/10.3390/biomedicines10112916
AMA Style
Sarikidi A, Kefalakes E, Falk CS, Esser R, Ganser A, Thau-Habermann N, Petri S.
Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS. Biomedicines. 2022; 10(11):2916.
https://doi.org/10.3390/biomedicines10112916
Chicago/Turabian Style
Sarikidi, Anastasia, Ekaterini Kefalakes, Christine S. Falk, Ruth Esser, Arnold Ganser, Nadine Thau-Habermann, and Susanne Petri.
2022. "Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS" Biomedicines 10, no. 11: 2916.
https://doi.org/10.3390/biomedicines10112916
APA Style
Sarikidi, A., Kefalakes, E., Falk, C. S., Esser, R., Ganser, A., Thau-Habermann, N., & Petri, S.
(2022). Altered Immunomodulatory Responses in the CX3CL1/CX3CR1 Axis Mediated by hMSCs in an Early In Vitro SOD1G93A Model of ALS. Biomedicines, 10(11), 2916.
https://doi.org/10.3390/biomedicines10112916